Ernexa Therapeutics Inc. Diluted Shares Outstanding (Weighted Average)
Ernexa Therapeutics Inc. (ERNA) reported Diluted Shares Outstanding (Weighted Average) of 1.18 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-06
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 1.18M shares, a 471.50% increase year-over-year.
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 792.00K shares, a 457.75% increase year-over-year.
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 8.26M shares, a 222.92% increase year-over-year.
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 8.23M shares, a 2178.67% increase year-over-year.
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 6.31M shares, a 593.08% increase from fiscal 2024.
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 910.00K shares, a 82.88% decline from fiscal 2023.
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 5.31M shares, a 74.17% increase from fiscal 2022.
- Ernexa Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 3.05M shares, a 40.92% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 1.18M shares 10-Q · filed 2026-08-06 | 989.00K shares 10-Q · filed 2026-08-06 | 3.41M shares derived: average of 3 quarters · filed 2026-08-06 | 4.61M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | 792.00K shares 10-Q · filed 2026-05-11 | 4.52M shares derived: average of 2 quarters · filed 2026-05-11 | 5.76M shares derived: average of 3 quarters · filed 2026-05-11 | 4.37M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | 8.26M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 8.24M shares derived: average of 2 quarters · filed 2026-03-13 | 5.56M shares derived: average of 3 quarters · filed 2026-08-06 | 6.31M shares 10-K · filed 2026-03-13 | ||||
| 2025-09-30 | 8.23M shares 10-Q · filed 2025-11-07 | 4.22M shares derived: average of 2 quarters · filed 2026-08-06 | 5.66M shares 10-Q · filed 2025-11-07 | 2.78M shares derived: average of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | 207.00K shares 10-Q · filed 2026-08-06 | 5.18M shares 10-Q · filed 2025-08-13 | 174.00K shares 10-Q · filed 2026-08-06 | 4.35M shares 10-Q · filed 2025-08-13 | 968.67K shares derived: average of 3 quarters · filed 2026-08-06 | 816.75K shares derived: average of 4 quarters · filed 2026-08-06 | ||
| 2025-03-31 | 142.00K shares 10-Q · filed 2026-05-11 | 53.36M shares 10-Q · filed 2025-05-07 | 1.35M shares derived: average of 2 quarters · filed 2026-05-11 | 1.02M shares derived: average of 3 quarters · filed 2026-05-11 | 855.25K shares derived: average of 4 quarters · filed 2026-05-11 | |||
| 2024-12-31 | 2.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-13 | 1.46M shares derived: average of 2 quarters · filed 2026-03-13 | 1.09M shares derived: average of 3 quarters · filed 2026-03-13 | 910.00K shares 10-K · filed 2026-03-13 | 13.65M shares 10-K · filed 2025-03-12 | |||
| 2024-09-30 | 361.00K shares 10-Q · filed 2025-11-07 | 5.41M shares 10-Q · filed 2024-11-12 | 361.00K shares derived: average of 2 quarters · filed 2025-11-07 | 361.00K shares 10-Q · filed 2025-11-07 | 5.41M shares 10-Q · filed 2024-11-12 | 2.89M shares derived: average of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | 361.00K shares 10-Q · filed 2025-08-13 | 5.41M shares 10-Q · filed 2024-08-13 | 361.00K shares 10-Q · filed 2025-08-13 | 5.41M shares 10-Q · filed 2024-08-13 | 3.73M shares derived: average of 3 quarters · filed 2025-08-13 | 4.15M shares derived: average of 4 quarters · filed 2025-08-13 | ||
| 2024-03-31 | 5.41M shares 10-Q · filed 2025-05-07 | 5.41M shares derived: average of 2 quarters · filed 2025-05-07 | 5.41M shares derived: average of 3 quarters · filed 2025-05-07 | 5.38M shares derived: average of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | 5.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-12 | 5.41M shares derived: average of 2 quarters · filed 2025-03-12 | 5.38M shares derived: average of 3 quarters · filed 2025-03-12 | 5.31M shares 10-K · filed 2025-03-12 | ||||
| 2023-09-30 | 5.41M shares 10-Q · filed 2024-11-12 | 5.36M shares derived: average of 2 quarters · filed 2024-11-12 | 5.28M shares 10-Q · filed 2024-11-12 | 4.87M shares derived: average of 4 quarters · filed 2024-11-12 | ||||
| 2023-06-30 | 5.30M shares 10-Q · filed 2024-08-13 | 5.21M shares 10-Q · filed 2024-08-13 | 4.69M shares derived: average of 3 quarters · filed 2024-08-13 | 4.25M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 5.13M shares 10-Q · filed 2024-05-14 | 4.38M shares derived: average of 2 quarters · filed 2024-05-14 | 3.90M shares derived: average of 3 quarters · filed 2024-05-14 | 3.66M shares derived: average of 4 quarters · filed 2024-05-14 | ||||
| 2022-12-31 | 3.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | 3.29M shares derived: average of 2 quarters · filed 2024-03-14 | 3.17M shares derived: average of 3 quarters · filed 2024-03-14 | 3.05M shares 10-K · filed 2024-03-14 | ||||
| 2022-09-30 | 2.94M shares 10-Q · filed 2023-11-13 | 2.94M shares derived: average of 2 quarters · filed 2023-11-13 | 2.85M shares 10-Q · filed 2023-11-13 | 2.79M shares derived: average of 4 quarters · filed 2023-11-13 | ||||
| 2022-06-30 | 2.94M shares 10-Q · filed 2023-08-11 | 58.80M shares 10-Q · filed 2022-08-11 | 2.81M shares 10-Q · filed 2023-08-11 | 56.23M shares 10-Q · filed 2022-08-11 | 2.74M shares derived: average of 3 quarters · filed 2023-08-11 | 2.69M shares derived: average of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | 2.68M shares 10-Q · filed 2023-05-11 | 53.63K shares 10-Q · filed 2022-07-01 | 2.64M shares derived: average of 2 quarters · filed 2023-05-11 | 2.60M shares derived: average of 3 quarters · filed 2023-05-11 | 12.57M shares derived: average of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | 2.61M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-20 | 2.57M shares derived: average of 2 quarters · filed 2023-03-20 | 15.86M shares derived: average of 3 quarters · filed 2023-03-20 | 2.17M shares 10-K · filed 2023-03-20 | 43.31M shares 10-K · filed 2022-04-15 | |||
| 2021-09-30 | 2.53M shares 10-Q · filed 2022-11-14 | 50.54M shares 10-Q · filed 2021-11-12 | 22.49M shares derived: average of 2 quarters · filed 2022-11-14 | 2.02M shares 10-Q · filed 2022-11-14 | 40.36M shares 10-Q · filed 2021-11-12 | 15.66M shares derived: average of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | 42.45M shares 10-Q · filed 2022-08-11 | 42.45M shares 10-Q · filed 2021-08-13 | 35.19M shares 10-Q · filed 2022-08-11 | 35.19M shares 10-Q · filed 2021-08-13 | 20.04M shares derived: average of 3 quarters · filed 2022-08-11 | 19.44M shares derived: average of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | 27.80K shares 10-Q · filed 2022-07-01 | 27.80M shares 10-Q · filed 2021-05-17 | 8.83M shares derived: average of 2 quarters · filed 2022-07-01 | 11.76M shares derived: average of 3 quarters · filed 2022-07-01 | 13.22M shares derived: average of 4 quarters · filed 2022-07-01 | |||
| 2020-12-31 | 17.64M shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-07-01 | 17.63M shares derived: average of 2 quarters · filed 2022-07-01 | 17.62M shares derived: average of 3 quarters · filed 2022-07-01 | 17.59M shares 10-K/A · filed 2022-07-01 | ||||
| 2020-09-30 | 17.63M shares 10-Q · filed 2021-11-12 | 17.61M shares derived: average of 2 quarters · filed 2021-11-12 | 17.57M shares 10-Q · filed 2021-11-12 | |||||
| 2020-06-30 | 17.58M shares 10-Q · filed 2021-08-13 | 17.54M shares 10-Q · filed 2021-08-13 | ||||||
| 2020-03-31 | 17.50M shares 10-Q · filed 2021-05-17 | |||||||
| 2019-09-30 | 2.87M shares 10-Q · filed 2019-11-01 | 2.87M shares 10-Q · filed 2019-11-01 | ||||||
| 2018-09-30 | 2.86M shares 10-Q · filed 2019-11-01 | 2.63M shares 10-Q · filed 2019-11-01 | ||||||
| 2013-09-30 | 71.20K shares 10-Q · filed 2013-11-14 | 71.04K shares 10-Q · filed 2013-11-14 | ||||||
| 2012-09-30 | 71.37K shares 10-Q · filed 2013-11-14 | 68.54K shares 10-Q · filed 2013-11-14 | ||||||
| 2011-09-30 | 60.40M shares 10-Q · filed 2011-11-14 | 60.39M shares 10-Q · filed 2011-11-14 | ||||||
| 2010-09-30 | 60.85M shares 10-Q · filed 2011-11-14 | 60.10M shares 10-Q · filed 2011-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |